{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:36:55Z","timestamp":1786649815935,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To compare immunohistochemical expression of CD34 and CD105 in oral submucous fibrosis (OSF) and normal oral mucosa (NOM) and correlate with clinicopathological features of OSF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>Total of thirty clinically diagnosed and histologically confirmed cases of OSF and 15 NOM were included in the study. Tissues sections were immunostained using CD34 and CD105 antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Twenty-eight cases (93.33%) were positive for CD34, and only 12 cases (40%) were positive for CD105 in OSF. In NOM all cases were positive for CD34 and only one case was positive for CD105. CD34 and CD105 significantly expressed in moderately advanced OSF when compared to very early, early, and advanced cases. It was found that the microvessel density (MVD) in NOM was significantly higher as compared to OSF and MVD decreased with advanced OSF. MVD was higher in CD34 when compared to CD105. MVD decreased with disease progression in OSF using both the markers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The role of CD34 in determining the premalignant nature of OSF could not be ascertained, since all endothelial cells were positive for CD34, whereas CD105 appeared to be more specific as it is associated with hypoxia-induced angiogenesis which is occurring in OSF due to hyalinization suggesting, CD105 to be more specific marker to determine neoangiogenesis in OSF. Thus further follow-up study of the cases positive for CD105 is required to determine the true nature of angiogenesis in OSF patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/0973-1482.181186","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T09:03:38Z","timestamp":1531991018000},"page":"983-988","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study"],"prefix":"10.4103","volume":"14","author":[{"given":"Chandrashekhar","family":"Pammar","sequence":"first","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Maratha Mandal's NG Halgekar Institute of Dental Sciences and Research Centre, Belgaum, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakan S.","family":"Nayak","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Maratha Mandal's NG Halgekar Institute of Dental Sciences and Research Centre, Belgaum, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi S.","family":"Kotrashetti","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Maratha Mandal's NG Halgekar Institute of Dental Sciences and Research Centre, Belgaum, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Hosmani","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology and Microbiology, Maratha Mandal's NG Halgekar Institute of Dental Sciences and Research Centre, Belgaum, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,9,7]]},"reference":[{"key":"R1-20260109","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1600-0528.1985.tb00468.x","article-title":"Malignant transformation rate in oral submucous fibrosis over a 17-year period","volume":"13","author":"Murti","year":"1985","journal-title":"Community Dent Oral Epidemiol"},{"key":"R3-20260109","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.oraloncology.2010.04.004","article-title":"Immunohistochemical expression of CD34 for characterization and quantification of mucosal vasculature and its probable role in malignant transformation of atrophic epithelium in oral submucous fibrosis","volume":"46","author":"Desai","year":"2010","journal-title":"Oral Oncol"},{"key":"R4-20260109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V87.1.1.1","article-title":"CD34: Structure, biology, and clinical utility","volume":"87","author":"Krause","year":"1996","journal-title":"Blood"},{"key":"R5-20260109","first-page":"151","article-title":"New marker of angiogenesis CD105 (endoglin); diagnostic, prognostic and therapeutic role","volume":"24","author":"Legan","year":"2005","journal-title":"Radiol Oncol"},{"key":"R6-20260109","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0714.2005.00325.x","article-title":"Molecular pathogenesis of oral submucous fibrosis \u2013 A collagen metabolic disorder","volume":"34","author":"Rajalalitha","year":"2005","journal-title":"J Oral Pathol Med"},{"key":"R7-20260109","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/154411130401500602","article-title":"TGF-\u03b2 signal transduction in oro-facial health and non-malignant disease (part I)","volume":"15","author":"Prime","year":"2004","journal-title":"Crit Rev Oral Biol Med"},{"key":"R8-20260109","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cardiores.2004.10.036","article-title":"TGF-\u03b2 receptor function in the endothelium","volume":"65","author":"Lebrin","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R9-20260109","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-90-481-3186-0_3","article-title":"Tumor angiogenesis in cancers. Expression of CD105 marker","volume":"7","author":"Tokunaga","year":"2010","journal-title":"Method Cancer Diagn Ther Prognosis"},{"key":"R10-20260109","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1078-0432.CCR-07-4478","article-title":"Endoglin (CD105): A marker of tumor vasculature and potential target for therapy","volume":"14","author":"Dallas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"R11-20260109","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0714.2010.00888.x","article-title":"CD105 is a marker of tumour vasculature and a potential target for the treatment of head and neck squamous cell carcinoma","volume":"39","author":"Marioni","year":"2010","journal-title":"J Oral Pathol Med"},{"key":"R12-20260109","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0714.1995.tb01209.x","article-title":"Clinical evaluation of different treatment methods for oral submucous fibrosis: a 10year experience with 150 cases","volume":"24","author":"Lai","year":"1995","journal-title":"J Oral Pathol Med"},{"key":"R13-20260109","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/jcp.2010.078964","article-title":"Assessment of malignant potential of oral submucous fibrosis through evaluation of p63, E-cadherin and CD105 expression","volume":"63","author":"Das","year":"2010","journal-title":"J Clin Pathol"},{"key":"R14-20260109","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oraloncology.2005.08.005","article-title":"Oral submucous fibrosis: Review on aetiology and pathogenesis","volume":"42","author":"Tilakaratne","year":"2006","journal-title":"Oral Oncol"},{"key":"R15-20260109","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/154405910808701111","article-title":"Areca-treated fibroblasts enhance tumorigenesis of oral epithelial cells","volume":"87","author":"Lu","year":"2008","journal-title":"J Dent Res"},{"key":"R16-20260109","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1600-0714.1999.tb01998.x","article-title":"Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes","volume":"28","author":"Jeng","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"R17-20260109","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1368-8375(01)00053-7","article-title":"Prevention of the areca nut extract-induced unscheduled DNA synthesis of gingival keratinocytes by Vitamin C and thiol compounds","volume":"38","author":"Chang","year":"2002","journal-title":"Oral Oncol"},{"key":"R18-20260109","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tox.2008.05.007","article-title":"Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells","volume":"249","author":"Tsai","year":"2008","journal-title":"Toxicology"},{"key":"R19-20260109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2334\/josnusd.56.173","article-title":"Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma","volume":"56","author":"Murgod","year":"2014","journal-title":"J Oral Sci"},{"key":"R20-20260109","first-page":"83","article-title":"Characterisation and quantification of mucosal vasculature in oral submucous fibrosis","volume":"16","author":"Rajendran","year":"2005","journal-title":"Indian J Dent Res"},{"key":"R21-20260109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0306-9877(89)90122-9","article-title":"An alternative pathogenetic pathway for oral submucous fibrosis (OSMF)","volume":"30","author":"Rajendran","year":"1989","journal-title":"Med Hypotheses"},{"key":"R22-20260109","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nature03096","article-title":"Stromal fibroblasts in cancer initiation and progression","volume":"432","author":"Bhowmick","year":"2004","journal-title":"Nature"},{"key":"R23-20260109","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","article-title":"What is the evidence that tumors are angiogenesis dependent?","volume":"82","author":"Folkman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"R24-20260109","first-page":"257","article-title":"Morphometric analysis in potentially malignant head and neck lesions: Oral submucous fibrosis","volume":"11","author":"Singh","year":"2010","journal-title":"Asian Pac J Cancer Prev"},{"key":"R25-20260109","first-page":"55","article-title":"A morphometric study on the microvessel in oral submucous fibrosis","volume":"25","author":"Fang","year":"2000","journal-title":"Hunan Yi Ke Da Xue Xue Bao"},{"key":"R26-20260109","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0970-9290.80009","article-title":"Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis","volume":"22","author":"Sabarinath","year":"2011","journal-title":"Indian J Dent Res"},{"key":"R27-20260109","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cancers5010149","article-title":"Carcinoma-associated fibroblasts are a promising therapeutic target","volume":"5","author":"Togo","year":"2013","journal-title":"Cancers (Basel)"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:58:43Z","timestamp":1786647523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814050-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/0973-1482.181186","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}